01 12GLAXOSMITHKLINE
01 38486941
02 39809559
03 311963962
04 3RE48285
01 6Y
02 6Blank
01 6Y
02 6Blank
01 32030-01-03
02 62035-06-11
03 32040-12-02
Patent Expiration Date : 2035-06-11
US Patent Number : 9809559
Drug Substance Claim :
Drug Product Claim :
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2035-06-11
Patent Expiration Date : 2035-06-11
US Patent Number : 9809559
Drug Substance Claim :
Drug Product Claim :
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2035-06-11
Patent Expiration Date : 2035-06-11
US Patent Number : 9809559
Drug Substance Claim :
Drug Product Claim :
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2035-06-11
Patent Expiration Date : 2030-01-03
US Patent Number : 8486941
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2030-01-03
Patent Expiration Date : 2030-01-03
US Patent Number : 8486941
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2030-01-03
Patent Expiration Date : 2030-01-03
US Patent Number : 8486941
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2030-01-03
Patent Expiration Date : 2035-06-11
US Patent Number : RE48285
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2035-06-11
Patent Expiration Date : 2035-06-11
US Patent Number : RE48285
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2035-06-11
Patent Expiration Date : 2035-06-11
US Patent Number : RE48285
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 216873
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2035-06-11
Patent Expiration Date : 2040-12-02
US Patent Number : 11963962
Drug Substance Claim :
Drug Product Claim :
Application Number : 216873
Patent Use Code : U-3928
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-12-02
